Inovio Pharmaceuticals, Inc.
INOFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Inovio Pharmaceuticals, Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 17 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated May 21, 2026.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2023-06-05 | Zoth Lota S. · Director | Common Stock | S — Open market or private sale | −5,700 | 0.56 | SEC filing |
Showing 1 of 1 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-05-20 | Shea Jacqueline Elizabeth · Chief Executive Officer | Restricted Stock Unit | M — Exercise or conversion of derivative security | −28,296 | SEC filing |
| 2026-05-20 | Shea Jacqueline Elizabeth · Chief Executive Officer | Common Stock | M — Exercise or conversion of derivative security | +28,296 | SEC filing |
| 2026-05-20 | KIES PETER · CFO | Common Stock | M — Exercise or conversion of derivative security | +8,700 | SEC filing |
| 2026-05-20 | Humeau Laurent · Chief Scientific Officer | Restricted Stock Unit | M — Exercise or conversion of derivative security | −6,027 | SEC filing |
| 2026-05-20 | Sumner Michael John · Chief Medical Officer | Restricted Stock Unit | M — Exercise or conversion of derivative security | −9,450 | SEC filing |
| 2026-05-20 | KIES PETER · CFO | Restricted Stock Unit | M — Exercise or conversion of derivative security | −8,700 | SEC filing |
| 2026-05-20 | Sumner Michael John · Chief Medical Officer | Common Stock | M — Exercise or conversion of derivative security | +9,450 | SEC filing |
| 2026-05-20 | Humeau Laurent · Chief Scientific Officer | Common Stock | M — Exercise or conversion of derivative security | +6,027 | SEC filing |
Showing 8 of 30 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.